CD4 and neoplasm: Laheurte et al. describe the properties of UCPVax, a CD4 helper cancer vaccine derived from telomerase that triggers polyfunctional Th1 cells with cytolytic properties, generates robust antibody responses, and promotes strong epitope spreading—factors that contribute to optimal tumor control.